NA Lymphedema Treatment Market - Industry Trends and Forecast to 2034
North America Lymphedema Treatment Market is expected to reach USD 1,019,834.36 thousand by 2030 from USD 475,938.11 thousand in 2022 growing at the CAGR of 10.2% in the forecast period of 2023 to 2030.
Market Segmentation: North America Lymphedema Treatment Market, By Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others), Treatment (Primary Lymphedema and Secondary Lymphedema), Affected Area (Genital, Lower Extremity, Upper Extremity, and Others), Age Group (Adult and Geriatric), Route of Administration (Oral, Injectable, and Others), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics, and Others), Distribution Channel (Direct tender, Pharmacy stores, and Others), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2030 Overview of North America Lymphedema Treatment Market Dynamics
Driver • Increasing number of healthcare facilities
Restrain
• Lack of awareness about the disease
Opportunity
• Partnership and agreement by market players
Market Players
Some of the key market players operating in the North America lymphedema treatment market are listed below:
• medi GmbH & Co. KG • PAUL HARTMANN AG • 3M • Convatec Inc. • JUZO • SIGVARIS GROUP • Sanyleg Srl a socio unico • AIROS Medical, Inc. • Tactile Medical • BIOCOMPRESSION SYSTEMS • Lohmann & Rauscher GmbH & Co. KG • Mego Afek ltd. • ThermoTek • Cardinal Health • Essity (BSN medical GmbH) • Smith+Nephew • HERANTIS PHARMA Plc • Huntleigh Healthcare Limited • Avet Pharmaceuticals Inc • KOYA MEDICAL
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Lymphedema Treatment Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Analysis
4.2 Porter's Model
5 Pipeline Analysis For North America Lymphedema Treatment Market
6 Epidemiology
7 Regulatory Guidelines For North America Lymphedema Treatment Market
7.1 U.S.
7.2 Europe
7.3 India
7.4 Mexico
7.5 Canada
8 Market Overview
8.1 Drivers
8.1.1 Rise In The Number Of Lymphedema Cases North Americaly
8.1.2 Increase In The Prevalence Of Cancers
8.1.3 Increasing Number Of Healthcare Facilities
8.1.4 Availability Of Multiple Therapies For Lymphedema
8.2 Restraints
8.2.1 High Cost Of Treatment
8.2.2 Lack Of Awareness About The Disease
8.3 Opportunities
8.3.1 Increasing Drug Approvals
8.3.2 Rising Partnerships And Agreements By Major Players
8.4 Challenges
8.4.1 No Permanent Cure For Lymphedema
8.4.2 Limited Reimbursement Scenario
9 North America Lymphedema Treatment Market, By Treatment Type
Table 88 Mexico Lymphedema Treatment Market, By Age Group, 2021-2030 (Usd Thousand)
Table 89 Mexico Lymphedema Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 90 Mexico Lymphedema Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 91 Mexico Lymphedema Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 North America Lymphedema Treatment Market: Segmentation
Figure 2 North America Lymphedema Treatment Market: Data Triangulation
Figure 3 North America Lymphedema Treatment Market: Droc Analysis
Figure 4 North America Lymphedema Treatment Market: North America Vs Regional Analysis
Figure 5 North America Lymphedema Treatment Market: Company Research Analysis
Figure 6 North America Lymphedema Treatment Market: Interview Demographics
Figure 7 North America Lymphedema Treatment Market: Dbmr Market Position Grid
Figure 8 North America Lymphedema Treatment Market: Market End User Coverage Grid
Figure 9 North America Lymphedema Treatment Market: Vendor Share Analysis
Figure 10 North America Lymphedema Treatment Market: Segmentation
Figure 11 Increasing Prevalence Of Lymphedema And Rising Healthcare Expenditure Are Expected To Drive The Growth Of The North America Lymphedema Treatment Market In The Forecast Period Of 2023 To 2030
Figure 12 The Compression Therapy Segment Is Expected To Account For The Largest Share Of The North America Lymphedema Treatment Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of North America Lymphedema Treatment Market
Figure 14 North America Lymphedema Treatment Market: By Treatment Type, 2022
Figure 15 North America Lymphedema Treatment Market: By Type, 2022
Figure 16 North America Lymphedema Treatment Market: By Affected Area, 2022
Figure 17 North America Lymphedema Treatment Market: By Age Group, 2022
Figure 18 North America Lymphedema Treatment Market: By Route Of Administration, 2022
Figure 19 North America Lymphedema Treatment Market: By End User, 2022
Figure 20 North America Lymphedema Treatment Market: By Distribution Channel, 2022
Figure 21 North America Lymphedema Treatment Market: Company Share 2022 (%)